Aquestive Therapeutics, Inc. (AQST)
3.53
-0.18
(-4.72%)
USD |
NASDAQ |
Nov 20, 14:04
Aquestive Therapeutics Price : 3.53 for Nov. 20, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 19, 2026 | 3.78 | 3.870 | 3.665 | 3.705 | 1.439M |
| Nov 18, 2026 | 3.70 | 3.905 | 3.66 | 3.78 | 1.806M |
| Nov 17, 2026 | 3.73 | 3.81 | 3.66 | 3.70 | 2.118M |
| Nov 16, 2026 | 3.88 | 3.95 | 3.71 | 3.76 | 2.000M |
| Nov 13, 2026 | 3.64 | 3.955 | 3.59 | 3.91 | 3.967M |
| Nov 12, 2026 | 3.56 | 3.68 | 3.45 | 3.57 | 2.796M |
| Nov 11, 2026 | 3.56 | 3.73 | 3.54 | 3.58 | 2.180M |
| Nov 10, 2026 | 3.51 | 3.63 | 3.475 | 3.52 | 2.559M |
| Nov 09, 2026 | 3.61 | 3.665 | 3.37 | 3.54 | 4.274M |
| Nov 06, 2026 | 3.71 | 3.76 | 3.55 | 3.61 | 4.144M |
| Nov 05, 2026 | 3.84 | 3.85 | 3.60 | 3.66 | 3.257M |
| Nov 04, 2026 | 3.66 | 4.045 | 3.65 | 3.80 | 3.315M |
| Nov 03, 2026 | 3.78 | 3.94 | 3.78 | 3.88 | 2.085M |
| Nov 02, 2026 | 3.92 | 3.96 | 3.635 | 3.77 | 2.635M |
| Oct 30, 2026 | 4.01 | 4.05 | 3.86 | 3.89 | 2.420M |
| Oct 29, 2026 | 4.17 | 4.29 | 3.99 | 4.04 | 2.018M |
| Oct 28, 2026 | 4.05 | 4.23 | 4.005 | 4.23 | 1.552M |
| Oct 27, 2026 | 4.00 | 4.075 | 3.92 | 4.07 | 1.325M |
| Oct 26, 2026 | 4.00 | 4.04 | 3.935 | 3.97 | 1.273M |
| Oct 23, 2026 | 4.08 | 4.135 | 3.97 | 4.00 | 1.747M |
| Oct 22, 2026 | 4.10 | 4.160 | 4.04 | 4.13 | 1.853M |
| Oct 21, 2026 | 4.08 | 4.185 | 4.020 | 4.08 | 1.573M |
| Oct 20, 2026 | 3.83 | 4.13 | 3.79 | 4.05 | 2.260M |
| Oct 19, 2026 | 3.80 | 3.85 | 3.65 | 3.83 | 3.335M |
| Oct 16, 2026 | 4.09 | 4.10 | 3.75 | 3.78 | 5.253M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Eton Pharmaceuticals, Inc. | 61.26 |
| Corcept Therapeutics, Inc. | 63.99 |
| ANI Pharmaceuticals, Inc. | 68.88 |
| Veru, Inc. | 2.025 |
| Johnson & Johnson | 271.75 |
Price Related Metrics
| PS Ratio | 8.947 |
| Earnings Yield | -18.16% |
| Market Cap | 443.68M |